Meyer Andrew Hollman
Insider CIK 1864159 · JANX Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics, Inc. | S Sale | 2026-01-02 | 2026-01-02 | 1,879 | $13.73 | $25.8K | 83,095 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2025-12-01 | 2025-12-03 | 3,333 | — | $0 | 114,768 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2025-12-01 | 2025-12-03 | 3,333 | $10.59 | $35.3K | 88,307 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-12-01 | 2025-12-03 | 2,700 | $32.85 | $88.7K | 85,607 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-12-01 | 2025-12-03 | 633 | $33.52 | $21.2K | 84,974 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2025-11-14 | 2025-11-14 | 3,333 | — | $0 | 118,101 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2025-11-14 | 2025-11-14 | 3,333 | $10.59 | $35.3K | 88,307 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-11-14 | 2025-11-14 | 3,333 | $30.00 | $100.0K | 84,974 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2025-10-28 | 2025-10-30 | 9,999 | — | $0 | 77,333 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2025-10-28 | 2025-10-30 | 6,666 | — | $0 | 121,434 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2025-10-28 | 2025-10-30 | 6,666 | $10.59 | $70.6K | 98,804 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2025-10-28 | 2025-10-30 | 9,999 | $4.21 | $42.1K | 92,138 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-30 | 16,665 | $30.06 | $500.9K | 82,139 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2025-05-01 | 2025-05-02 | 3,333 | — | $0 | 87,332 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2025-05-01 | 2025-05-02 | 3,333 | $4.21 | $14.0K | 85,472 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-05-01 | 2025-05-02 | 2,933 | $31.95 | $93.7K | 82,539 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-05-01 | 2025-05-02 | 400 | $32.60 | $13.0K | 82,139 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2025-04-21 | 2025-04-23 | 3,334 | — | $0 | 90,665 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2025-04-21 | 2025-04-23 | 3,334 | $4.21 | $14.0K | 85,473 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-04-21 | 2025-04-23 | 3,334 | $30.00 | $100.0K | 82,139 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2025-03-03 | 2025-03-05 | 3,334 | — | $0 | 93,999 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-05 | 2,433 | $31.88 | $77.6K | 83,040 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-05 | 901 | $32.85 | $29.6K | 82,139 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2025-03-03 | 2025-03-05 | 3,334 | $4.21 | $14.0K | 85,473 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2025-02-03 | 2025-02-05 | 3,334 | — | $0 | 97,333 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2025-02-03 | 2025-02-05 | 3,334 | $4.21 | $14.0K | 85,473 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-05 | 2,418 | $42.08 | $101.7K | 83,055 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-05 | 816 | $42.77 | $34.9K | 82,239 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-05 | 100 | $43.60 | $4.4K | 82,139 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 63,000 | — | $0 | 63,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 200 | $57.37 | $11.5K | 82,139 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 3,444 | $55.76 | $192.0K | 83,339 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 1,000 | $56.78 | $56.8K | 82,339 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2025-01-02 | 2025-01-03 | 18,000 | — | $0 | 95,473 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 2,922 | $53.76 | $157.1K | 92,551 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-03 | 5,768 | $54.51 | $314.4K | 86,783 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-12-19 | 2024-12-20 | 1 | — | $0 | 89,999 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-12-19 | 2024-12-20 | 9,880 | — | $0 | 96,870 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-12-19 | 2024-12-20 | 9,880 | $20.24 | $200.0K | 77,472 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-12-19 | 2024-12-20 | 1 | $14.02 | $14 | 77,473 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-09-27 | 50,000 | — | $0 | 100,667 | SEC↗ |
| JANX Janux Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-09-27 | 50,000 | $4.21 | $210.5K | 117,592 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-09-27 | 50,000 | $45.96 | $2.30M | 67,592 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-03 | 105,000 | — | $0 | 105,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 106,750 | — | $0 | 106,750 | SEC↗ |